Recombinant multi-species IL-15/IL15 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-15/IL15 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a cytokine that regulates T and natural killer cell activation and proliferation. This cytokine and interleukine 2 share many biological activities. They are found to bind common hematopoietin receptor subunits, and may compete for the same receptor, and thus negatively regulate each other's activity. The number of CD8+ memory cells is shown to be controlled by a balance between this cytokine and IL2. This cytokine induces the activation of JAK kinases, as well as the phosphorylation and activation of transcription activators STAT3, STAT5, and STAT6. Studies of the mouse counterpart suggested that this cytokine may increase the expression of apoptosis inhibitor BCL2L1/BCL-x(L), possibly through the transcription activation activity of STAT6, and thus prevent apoptosis. Alternatively spliced transcript variants of this gene have been reported. [provided by RefSeq, Feb 2011]
The Alternative Names of target: IL-15,IL15,Il15,Interleukin-15
Go
to IL-15/IL15 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T32240-Ag-1/ GM-Tg-hg-T32240-Ag-2 | Human IL-15/IL15 protein | Human |
| GM-Tg-rg-T32240-Ag-1/ GM-Tg-rg-T32240-Ag-2 | Rat IL-15/IL15 protein | Rat |
| GM-Tg-mg-T32240-Ag-1/ GM-Tg-mg-T32240-Ag-2 | Mouse IL-15/IL15 protein | Mouse |
| GM-Tg-cynog-T32240-Ag-1/ GM-Tg-cynog-T32240-Ag-2 | Cynomolgus/Rhesus macaque IL-15/IL15 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T32240-Ag-1/ GM-Tg-felg-T32240-Ag-2 | Feline IL-15/IL15 protein | Feline |
| GM-Tg-cang-T32240-Ag-1/ GM-Tg-cang-T32240-Ag-2 | Canine IL-15/IL15 protein | Canine |
| GM-Tg-bovg-T32240-Ag-1/ GM-Tg-bovg-T32240-Ag-2 | Bovine IL-15/IL15 protein | Bovine |
| GM-Tg-equg-T32240-Ag-1/ GM-Tg-equg-T32240-Ag-2 | Equine IL-15/IL15 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T32240-Ag-1/ GM-Tg-hg-T32240-Ag-2;
GM-Tg-rg-T32240-Ag-1/ GM-Tg-rg-T32240-Ag-2;
GM-Tg-mg-T32240-Ag-1/ GM-Tg-mg-T32240-Ag-2; GM-Tg-cynog-T32240-Ag-1/ GM-Tg-cynog-T32240-Ag-2; GM-Tg-felg-T32240-Ag-1/ GM-Tg-felg-T32240-Ag-2; GM-Tg-cang-T32240-Ag-1/ GM-Tg-cang-T32240-Ag-2; GM-Tg-bovg-T32240-Ag-1/ GM-Tg-bovg-T32240-Ag-2; GM-Tg-equg-T32240-Ag-1/ GM-Tg-equg-T32240-Ag-2 |
| Products Name | IL-15/IL15 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | IL-15/IL15 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-15/IL15 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.